Letter to the Industry: Clarifying FTC’s Stance on Structure-Function Claim Substantiation

KGK-Science-KGK-Letter-to-the-Industry-1

Latest Post

October 3, 2025

KGK Science Secures Class III PLA for Qlarity™, Supporting Lucid Psycheceutical’s Successful Path to Market in Canada

October 3, 2025

Can A Small Patch make a BIG Difference in Healthy Aging?

September 19, 2025

Probiotic and Children’s Immune Health Study

September 18, 2025

Can A Small Patch make a BIG Difference in Moderate Stress?

Our Newslater Resource

Lorem ipsum dolor sit amet, consectetur adipiscing elit sed do eiusmod tempor

Subscribe to Our Newsletter

Lorem ipsum dolor sit amet consectetur adipiscing elit.

KGK Science has been delivering top-notch clinical research trials and expert regulatory support for the nutraceutical, cannabis, hemp, and psychedelic industries for over 27 years, aiding companies in bringing their products to global markets with custom trials and claim substantiation strategies.